A Multicenter, Non-interventional Prospective Active Surveillance Study Among Participants Receiving Somatrogon Under Routine Clinical Care in India
Latest Information Update: 28 May 2025
At a glance
- Drugs Somatrogon (Primary)
- Indications Somatotropin deficiency
- Focus Adverse reactions
- Sponsors Pfizer
Most Recent Events
- 18 Mar 2025 Status changed from not yet recruiting to recruiting.
- 21 Feb 2025 Planned initiation date changed from 5 Feb 2025 to 1 Feb 2025.
- 08 Jan 2025 Planned number of patients changed from 100 to 50.